ALLERTNESS AID- caffeine tablet 
Chain Drug Consortium

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Drug Facts

Active ingredient

Caffeine 200 mg

Purpose

Alertness aid

Uses

helps restore mental alertness or wakefulness when experiencing fatigue or drowsiness

Warnings

For occasional use only

Do Not Use

in children under 12 years of age as a substitute for sleep

When Using this product

limit the use of caffeine containing medications, foods, or beverages because too much caffeine may cause nervousness, irritability, sleeplessness, and occasionally rapid heartbeat.

The recommended dose of this product contains about as much caffeine as a cup of coffee.

Stop Use and ask a doctor if

fatigue or drowsiness persists or continues to occur . For occasional use only.

If pregnancy or breast-feeding

ask a health professional before use.

Keep Out of Reach of Children

In case of accidental overdose, contact a doctor or Poison Control Center right away.

Directions

Adults and children 12 years of age and older: take 1 tablet not more often than every 3 to 4 hours
Children under 12 years of age: Do not use

Inactive Ingredients

colloidal silicon dioxide, croscarmellose sodium, D&C yellow #10, dicalcium phosphate dihydrate, FD&C yellow #6, hydroxypropyl methylcellulose, magnesium stearate, microcrystalline cellulose, propylene glycol, titanium dioxide, triacetin

Package/Label Principal Display Panel

Z:\SPL-OTC Mono\PV\Allertness Aid\LB1320.jpg
ALLERTNESS AID 
caffeine tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68016-195
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CAFFEINE (UNII: 3G6A5W338E) (CAFFEINE - UNII:3G6A5W338E) CAFFEINE200 mg
Inactive Ingredients
Ingredient NameStrength
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE (UNII: O7TSZ97GEP)  
FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
HYPROMELLOSES (UNII: 3NXW29V3WO)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
TRIACETIN (UNII: XHX3C3X673)  
Product Characteristics
ColoryellowScoreno score
ShapeROUNDSize11mm
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:68016-195-0316 in 1 BOX; Type 0: Not a Combination Product11/03/201410/01/2018
2NDC:68016-195-1140 in 1 BOX; Type 0: Not a Combination Product11/03/201410/01/2018
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart34311/03/201410/01/2018
Labeler - Chain Drug Consortium (101668460)
Registrant - Chain Drug Consortium (101668460)
Establishment
NameAddressID/FEIBusiness Operations
A&Z Pharmaceutical, Inc.926820705label(68016-195) , manufacture(68016-195) , pack(68016-195) , relabel(68016-195) , repack(68016-195)

Revised: 10/2018
 
Chain Drug Consortium